Capricor Therapeutics (CAPR) Assets Average (2016 - 2025)
Historic Assets Average for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $130.0 million.
- Capricor Therapeutics' Assets Average rose 9813.23% to $130.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.0 million, marking a year-over-year increase of 9813.23%. This contributed to the annual value of $114.6 million for FY2024, which is 11061.93% up from last year.
- Capricor Therapeutics' Assets Average amounted to $130.0 million in Q3 2025, which was up 9813.23% from $143.7 million recorded in Q2 2025.
- Over the past 5 years, Capricor Therapeutics' Assets Average peaked at $162.1 million during Q1 2025, and registered a low of $39.1 million during Q1 2021.
- Moreover, its 5-year median value for Assets Average was $52.0 million (2022), whereas its average is $68.9 million.
- In the last 5 years, Capricor Therapeutics' Assets Average crashed by 2574.27% in 2023 and then soared by 22755.22% in 2025.
- Quarter analysis of 5 years shows Capricor Therapeutics' Assets Average stood at $42.2 million in 2021, then increased by 23.2% to $52.0 million in 2022, then dropped by 7.82% to $47.9 million in 2023, then skyrocketed by 174.73% to $131.7 million in 2024, then fell by 1.3% to $130.0 million in 2025.
- Its Assets Average stands at $130.0 million for Q3 2025, versus $143.7 million for Q2 2025 and $162.1 million for Q1 2025.